The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery
Authors:
- 1 December 2013
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 6 (6) , 677-695
Abstract
Venous thromboembolism is a common cause of morbidity and mortality among patients undergoing elective orthopedic surgery. Due to the high incidence of venous thromboembolism in this setting, perio...Keywords
This publication has 90 references indexed in Scilit:
- Symptomatic venous thromboembolism and mortality in orthopaedic surgery – an observational study of 45 968 consecutive proceduresBMC Musculoskeletal Disorders, 2013
- Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgeryThrombosis and Haemostasis, 2013
- Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoringThrombosis Journal, 2013
- Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: Pool-analysis of phase III randomized clinical trialsThrombosis Research, 2012
- Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgeryVascular Health and Risk Management, 2012
- Preventing Venous Thromboembolic Disease in Patients Undergoing Elective Total Hip and Knee ArthroplastyJournal of Bone and Joint Surgery, 2012
- Prevention of VTE in Orthopedic Surgery PatientsChest, 2012
- Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trialsThrombosis Journal, 2012
- Interaction of Antithrombin with Sulfated, Low Molecular Weight LigninsJournal of Biological Chemistry, 2009
- The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBritish Journal of Clinical Pharmacology, 2007